Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymeric Micelles vs TPC in HER2- MBC
NCT06143553Phase 3Recruiting
- Sponsor
- Shanghai Yizhong Pharmaceutical Co., Ltd.
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in breast cancer, sponsored by Shanghai Yizhong Pharmaceutical Co., Ltd.. Started Sep 2023; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06143553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06143553.